Schizophrenia Bulletin Advance Access originally published online on November 17, 2005
Schizophrenia Bulletin 2006 32(1):81-91; doi:10.1093/schbul/sbj027
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Capacity in Persons with Schizophrenia and Serious Mental Illness: Clinical and Research Ethics Aspects
2 Department of Neurology
3 Alzheimer's Disease Research Center
4 Department of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham
1To whom correspondence should be addressed; Department of Neurology, Room JT1216, University of Alabama at Birmingham, Birmingham, AL 35233-7340, e-mail: dmarson{at}uab.edu.
In contrast with issues of consent capacity, financial capacity has received surprisingly little clinical or ethical attention in the psychiatric literature. Issues of financial capacity emerge frequently regarding clients with serious mental illness (SMI), and their resolution has practical and ethical significance for clients, their families, and mental health professionals. These issues include whether a client has sufficient financial skills and judgment to live independently, whether a client requires a representative payee, and what goals for community reintegration should be established with a client. Similar to informed consent, issues of financial capacity raise ethical challenges for clinicians, caseworkers, and agencies. The present article addresses clinical and research ethics questions related to financial capacity in clients with schizophrenia and SMI. Clinical questions concern evaluation of financial capacity in clients with SMI, whether to seek assignment of a mandatory representative payee, whether to leverage treatment compliance through a representative payee arrangement, and whether a mental health professional should also serve as a client's representative payee. The research ethics question addresses implications of providing financial compensation for research participation to individuals with SMI and limited financial capacity and means. The ultimate goal of this article is to focus clinical and ethical attention on a neglected decisional capacity in SMI that is of fundamental importance for clients, families, clinicians, and researchers.
Keywords: financial capacity / ethics / schizophrenia / SMI / representative payee
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  L. L. Moser and G. R. Bond The Role of Coercion in Public Mental Health Practice: Reply Psychiatr Serv, September 1, 2009; 60(9): 1273 - 1274. [Full Text] [PDF]
|
|
|
|
 |
|
 L. B. Dunn, D. S. Kim, I. E. Fellows, and B. W. Palmer Worth the Risk? Relationship of Incentives to Risk and Benefit Perceptions and Willingness to Participate in Schizophrenia Research Schizophr Bull, July 1, 2009; 35(4): 730 - 737. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. B. Elbogen, C. Wilder, M. S. Swartz, and J. W. Swanson Caregivers as Money Managers for Adults with Severe Mental Illness: How Treatment Providers Can Help Acad Psychiatry, April 1, 2008; 32(2): 104 - 110. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. B. Elbogen, J. C. Ferron, M. S. Swartz, C. M. Wilder, J. W. Swanson, and H. R. Wagner Characteristics of Representative Payeeship Involving Families of Beneficiaries With Psychiatric Disabilities Psychiatr Serv, November 1, 2007; 58(11): 1433 - 1440. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Fitch, R. Chaplin, C. Trend, and S. Collard Debt and mental health: the role of psychiatrists Adv. Psychiatr. Treat., May 1, 2007; 13(3): 194 - 202. [Abstract] [Full Text] [PDF]
|
|